Mental Health Chatbot Woebot Shown to Help with Postpartum Depression and Anxiety
Key Points:
1. In a randomized controlled trial, use of Woebot, a mental health chatbot, significantly reduced symptoms of postpartum depression and anxiety compared to waitlist controls.
2. Improvements were observed as early as two weeks into the intervention and sustained at six weeks, with large effect sizes across multiple psychometric scales.
Postpartum depression and anxiety remain underrecognized and undertreated among new mothers, often due to stigma, lack of time, or limited mental health resources. A recent randomized controlled trial (RCT) evaluated the use of Woebot, a smartphone-based chatbot powered by artificial intelligence, to deliver cognitive behavioral therapy (CBT) to postpartum women. The trial enrolled 184 participants within six months of childbirth who screened positive for symptoms using the Edinburgh Postnatal Depression Scale (EPDS) or the Generalized Anxiety Disorder-7 (GAD-7) assessment. Participants were randomly assigned to either a six-week Woebot program or a waitlist control group. The chatbot provided daily CBT-based exercises, emotional support, and conversational check-ins using natural language processing. By week six, participants using Woebot showed significantly greater reductions in both depression and anxiety symptoms. The mean EPDS score dropped by over five points in the intervention group compared to just one point in controls, while GAD-7 scores also improved meaningfully. Over 70 percent of the Woebot users achieved a clinically significant improvement on at least one scale, compared to only 30 percent of those in the control group. The tool was well tolerated, with no adverse events reported and high levels of user satisfaction. Engagement was strong, with participants averaging nearly five interactions per week. Researchers emphasized that Woebot is not a replacement for in-person care but could be an early or supplemental option for those lacking access to therapy. As a scalable, low-cost solution, it could play a key role in expanding postpartum mental health support to underserved populations.
Relevant reading: Woebot chatbot reduces postpartum depression and anxiety in randomized trial
©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.
